|
||||||||||||||||||
Data:2009-12-12 2:34
Author: Lu Jian
Golden shares (600.08 thousand) Company for the medical technology business, its mastery of the biological activity of stable technology products belong to the world's biological engineering cutting-edge technology can be widely used in bio-pharmaceutical industry to address the biological products is not easy to save the problem. A class of drugs golden days of the national grid capsules, artificial tiger bone meal, pre-market development to achieve good results, as the current share price is only 2 yuan a number of technology stocks, is not the look.
Historical Information: G Golden Flower (600.08 thousand): short-term break up adequate attention to July 12, 2006
Source: Masukuni Investment
The company is a biopharmaceutical company, is a key pharmaceutical enterprises in Shaanxi province, produced in the local hypericin in the anti-bird flu is expected to play an important role in the process. Biological activity of the company acquired a stable technology, bio-engineering part of the world's cutting-edge technology. As the national macro-policy adjustment medicine and the pharmaceutical industry is highly competitive, the company operating performance deteriorating, is now in the first half of this year will notice a loss.
From the secondary market trends point of view, since the shares resume trading reform has been completed, showing a slight upward trend in shock, obviously, incremental funding to intervene yesterday, with the entire medical section started up the offensive. Recommended amount of attention.